drugset / Trial / NCT00259038

Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure

NCT00259038 ↗

Phase 2 Completed 162 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will evaluate the safety and efficacy of intravenous infusion of carperitide using pressure measurements inside the heart and great vessels and measuring carperitide concentration in the blood.

Timeline

Start
2004-01
Primary completion
2006-02
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Carperitide Peptide — Intravenous